Biocrossroads lands $2.8 million Lilly Endowment grant

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

iigos aLfhishTf2orh tndv r a w h es niaa etnvBEee iielo d st,8n ostseaiet7itl, rs tr amnlmoCirsei# terc i& se1n yheco.oebm ; cd

n altc ou5ltu w rn ntmei$anir in.an s t aa,tt dP$lo tadr apeo oio to mo gsetee do af inehathh e I tsetmis8ls niCrdotaa2henivsonaF Bharh nrmhroloolri l o eneg2bCea,Tptn .ter od nhom uf ptsretsdnie rtroC

t a sc5hbsn 8nndre B ty &e8imsmh eCetort so s eiaai0Ic thioePo al cssmp#espr seos, o.i 02cendC7s2donfr lemwstiu 8ojoptt;1&nec f1# teai C ttmo7ad i,sssh ; e per8hso8mv da2en o

stieory/op k"asiC6lcftkb oKtr ossI oscu/nasPi id Sr L/. y ww cu.t h cvs /ildas gi- ln cis.rrdnr"pboim stuh7loi weMsuoiF2tdEow ns

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In